-
1
-
-
0027455361
-
The epidemiology of thyroid carcinoma
-
Franceschi S, Boyle P, Maisonneuve P, La Vecchia C, Burt AD, Kerr DJ, MacFarlane GJ 1993 The epidemiology of thyroid carcinoma. Crit Rev Oncog 4:25-52.
-
(1993)
Crit Rev Oncog
, vol.4
, pp. 25-52
-
-
Franceschi, S.1
Boyle, P.2
Maisonneuve, P.3
La Vecchia, C.4
Burt, A.D.5
Kerr, D.J.6
MacFarlane, G.J.7
-
2
-
-
0037317623
-
Role of percutaneous ethanol injection in management of nodular lesions of the thyroid gland
-
Pacini F 2003 Role of percutaneous ethanol injection in management of nodular lesions of the thyroid gland. J Nucl Med 44:211-212.
-
(2003)
J Nucl Med
, vol.44
, pp. 211-212
-
-
Pacini, F.1
-
3
-
-
33646828701
-
Genetics of papillary thyroid cancer initiation: Implications for therapy
-
discussion 269-271
-
Fagin JA 2005 Genetics of papillary thyroid cancer initiation: implications for therapy. Trans Am Clin Climatol Assoc 116:259-269; discussion 269-271.
-
(2005)
Trans Am Clin Climatol Assoc
, vol.116
, pp. 259-269
-
-
Fagin, J.A.1
-
4
-
-
35348823686
-
Molecular genetics of papillary thyroid carcinoma: Great expectations
-
Trovisco V, Soares P, Preto A, Castro P, Maximo V, Sobrinho-Simoes M 2007 Molecular genetics of papillary thyroid carcinoma: great expectations. Arq Bras Endocrinol Metabol 51:643-653.
-
(2007)
Arq Bras Endocrinol Metabol
, vol.51
, pp. 643-653
-
-
Trovisco, V.1
Soares, P.2
Preto, A.3
Castro, P.4
Maximo, V.5
Sobrinho-Simoes, M.6
-
5
-
-
0037379904
-
High prevalence of BRAF mutations in thyroid cancer: Genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma
-
Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA 2003 High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res 63:1454-1457.
-
(2003)
Cancer Res
, vol.63
, pp. 1454-1457
-
-
Kimura, E.T.1
Nikiforova, M.N.2
Zhu, Z.3
Knauf, J.A.4
Nikiforov, Y.E.5
Fagin, J.A.6
-
6
-
-
56649105350
-
Molecular pathology of thyroid cancer: Diagnostic and clinical implications
-
Fagin JA, Mitsiades N 2008 Molecular pathology of thyroid cancer: diagnostic and clinical implications. Best Pract Res Clin Endocrinol Metab 22:955-969.
-
(2008)
Best Pract Res Clin Endocrinol Metab
, vol.22
, pp. 955-969
-
-
Fagin, J.A.1
Mitsiades, N.2
-
7
-
-
10744222003
-
BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas
-
Nikiforova MN, Kimura ET, Gandhi M, Biddinger PW, Knauf JA, Basolo F, Zhu Z, Giannini R, Salvatore G, Fusco A, Santoro M, Fagin JA, Nikiforov YE 2003 BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 88:5399-5404.
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 5399-5404
-
-
Nikiforova, M.N.1
Kimura, E.T.2
Gandhi, M.3
Biddinger, P.W.4
Knauf, J.A.5
Basolo, F.6
Zhu, Z.7
Giannini, R.8
Salvatore, G.9
Fusco, A.10
Santoro, M.11
Fagin, J.A.12
Nikiforov, Y.E.13
-
8
-
-
24144464215
-
The T1799A BRAF mutation is not a germline mutation in familial nonmedullary thyroid cancer
-
Xing M 2005 The T1799A BRAF mutation is not a germline mutation in familial nonmedullary thyroid cancer. Clin Endocrinol (Oxf) 63:263-266.
-
(2005)
Clin Endocrinol (Oxf)
, vol.63
, pp. 263-266
-
-
Xing, M.1
-
9
-
-
4143051232
-
BRAF mutations in an Italian cohort of thyroid cancers
-
Fugazzola L, Mannavola D, Cirello V, Vannucchi G, Muzza M, Vicentini L, Beck-Peccoz P 2004 BRAF mutations in an Italian cohort of thyroid cancers. Clin Endocrinol (Oxf) 61:239-243.
-
(2004)
Clin Endocrinol (Oxf)
, vol.61
, pp. 239-243
-
-
Fugazzola, L.1
Mannavola, D.2
Cirello, V.3
Vannucchi, G.4
Muzza, M.5
Vicentini, L.6
Beck-Peccoz, P.7
-
10
-
-
38349140435
-
Identification of differentially expressed proteins in papillary thyroid carcinomas with V600E mutation of BRAF
-
Puxeddu E, Susta F, Orvietani PL, Chiasserini D, Barbi F, Moretti S, Cavaliere A, Santeusanio F, Avenia N, Binaglia L 2007 Identification of differentially expressed proteins in papillary thyroid carcinomas with V600E mutation of BRAF. Proteomics Clin Appl 1:672-680.
-
(2007)
Proteomics Clin Appl
, vol.1
, pp. 672-680
-
-
Puxeddu, E.1
Susta, F.2
Orvietani, P.L.3
Chiasserini, D.4
Barbi, F.5
Moretti, S.6
Cavaliere, A.7
Santeusanio, F.8
Avenia, N.9
Binaglia, L.10
-
11
-
-
24644436920
-
Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans
-
Maia AL, Kim BW, Huang SA, Harney JW, Larsen PR 2005 Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans. J Clin Invest 115:2524-2533.
-
(2005)
J Clin Invest
, vol.115
, pp. 2524-2533
-
-
Maia, A.L.1
Kim, B.W.2
Huang, S.A.3
Harney, J.W.4
Larsen, P.R.5
-
12
-
-
18244397978
-
Gene expression in papillary thyroid carcinoma reveals highly consistent profiles
-
Huang Y, Prasad M, Lemon WJ, Hampel H, Wright FA, Kornacker K, LiVolsi V, Frankel W, Kloos RT, Eng C, Pellegata NS, de la Chapelle A 2001 Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proc Natl Acad Sci USA 98:15044-15049.
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 15044-15049
-
-
Huang, Y.1
Prasad, M.2
Lemon, W.J.3
Hampel, H.4
Wright, F.A.5
Kornacker, K.6
Livolsi, V.7
Frankel, W.8
Kloos, R.T.9
Eng, C.10
Pellegata, N.S.11
De La Chapelle, A.12
-
13
-
-
79958213271
-
Deiodinases: The balance of thyroid hormone: Type 1 iodothyronine deiodinase in human physiology and disease
-
Maia AL, Goemann IM, Meyer EL, Wajner SM 2011 Deiodinases: the balance of thyroid hormone: type 1 iodothyronine deiodinase in human physiology and disease. J Endocrinol 209:283-297.
-
(2011)
J Endocrinol
, vol.209
, pp. 283-297
-
-
Maia, A.L.1
Goemann, I.M.2
Meyer, E.L.3
Wajner, S.M.4
-
14
-
-
0037328829
-
Overexpression of type 2 iodothyronine deiodinase in follicular carcinoma as a cause of low circulating free thyroxine levels
-
Kim BW, Daniels GH, Harrison BJ, Price A, Harney JW, Larsen PR, Weetman AP 2003 Overexpression of type 2 iodothyronine deiodinase in follicular carcinoma as a cause of low circulating free thyroxine levels. J Clin Endocrinol Metab 88:594-598.
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 594-598
-
-
Kim, B.W.1
Daniels, G.H.2
Harrison, B.J.3
Price, A.4
Harney, J.W.5
Larsen, P.R.6
Weetman, A.P.7
-
15
-
-
45049087608
-
Type 2 iodothyronine deiodinase is highly expressed in medullary thyroid carcinoma
-
Meyer EL, Goemann IM, Dora JM, Wagner MS, Maia AL 2008 Type 2 iodothyronine deiodinase is highly expressed in medullary thyroid carcinoma. Mol Cell Endocrinol 289: 16-22.
-
(2008)
Mol Cell Endocrinol
, vol.289
, pp. 16-22
-
-
Meyer, E.L.1
Goemann, I.M.2
Dora, J.M.3
Wagner, M.S.4
Maia, A.L.5
-
17
-
-
35448945645
-
Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes
-
Dentice M, Luongo C, Huang S, Ambrosio R, Elefante A, Mirebeau-Prunier D, Zavacki AM, Fenzi G, Grachtchouk M, Hutchin M, Dlugosz AA, Bianco AC, Missero C, Larsen PR, Salvatore D 2007 Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes. Proc Natl Acad Sci USA 104:14466-14471.
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, pp. 14466-14471
-
-
Dentice, M.1
Luongo, C.2
Huang, S.3
Ambrosio, R.4
Elefante, A.5
Mirebeau-Prunier, D.6
Zavacki, A.M.7
Fenzi, G.8
Grachtchouk, M.9
Hutchin, M.10
Dlugosz, A.A.11
Bianco, A.C.12
Missero, C.13
Larsen, P.R.14
Salvatore, D.15
-
18
-
-
0024514347
-
The WHO histological classification of thyroid tumors: A commentary on the second edition
-
Hedinger C, Williams ED, Sobin LH 1989 The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 63:908-911.
-
(1989)
Cancer
, vol.63
, pp. 908-911
-
-
Hedinger, C.1
Williams, E.D.2
Sobin, L.H.3
-
19
-
-
0036300877
-
The TNM system: Our language for cancer care
-
Greene FL, Sobin LH 2002 The TNM system: our language for cancer care. J Surg Oncol 80:119-120.
-
(2002)
J Surg Oncol
, vol.80
, pp. 119-120
-
-
Greene, F.L.1
Sobin, L.H.2
-
20
-
-
66649091781
-
Life without thyroxine to 3, 5, 3′-triiodothyronine conversion: Studies in mice devoid of the 5′-deiodinases
-
Galton VA, Schneider MJ, Clark AS, St. Germain DL 2009 Life without thyroxine to 3, 5, 3′-triiodothyronine conversion: studies in mice devoid of the 5′-deiodinases. Endocrinology 150:2957-2963.
-
(2009)
Endocrinology
, vol.150
, pp. 2957-2963
-
-
Galton, V.A.1
Schneider, M.J.2
Clark, A.S.3
St. Germain, D.L.4
-
21
-
-
79955499181
-
IL-6 promotes nonthyroidal illness syndrome by blocking thyroxine activation while promoting thyroid hormone inactivation in human cells
-
Wajner SM, Goemann IM, Bueno AL, Larsen PR, Maia AL 2011 IL-6 promotes nonthyroidal illness syndrome by blocking thyroxine activation while promoting thyroid hormone inactivation in human cells. J Clin Invest 121:1834-1845.
-
(2011)
J Clin Invest
, vol.121
, pp. 1834-1845
-
-
Wajner, S.M.1
Goemann, I.M.2
Bueno, A.L.3
Larsen, P.R.4
Maia, A.L.5
-
22
-
-
28144445400
-
Transforming growth factor-beta promotes inactivation of extracellular thyroid hormones via transcriptional stimulation of type 3 iodothyronine deiodinase
-
Huang SA, Mulcahey MA, Crescenzi A, Chung M, Kim BW, Barnes C, Kuijt W, Turano H, Harney J, Larsen PR 2005 Transforming growth factor-beta promotes inactivation of extracellular thyroid hormones via transcriptional stimulation of type 3 iodothyronine deiodinase. Mol Endocrinol 19:3126-3136.
-
(2005)
Mol Endocrinol
, vol.19
, pp. 3126-3136
-
-
Huang, S.A.1
Mulcahey, M.A.2
Crescenzi, A.3
Chung, M.4
Kim, B.W.5
Barnes, C.6
Kuijt, W.7
Turano, H.8
Harney, J.9
Larsen, P.R.10
-
23
-
-
0022375782
-
Skin is an active site for the inner ring monodeiodination of thyroxine to 3, 3′, 5′-triiodothyronine
-
Huang TS, Chopra IJ, Beredo A, Solomon DH, Chua Teco GN 1985 Skin is an active site for the inner ring monodeiodination of thyroxine to 3, 3′, 5′-triiodothyronine. Endocrinology 117:2106-2113.
-
(1985)
Endocrinology
, vol.117
, pp. 2106-2113
-
-
Huang, T.S.1
Chopra, I.J.2
Beredo, A.3
Solomon, D.H.4
Chua Teco, G.N.5
-
24
-
-
0032908826
-
Expression profiles of the three iodothyronine deiodinases, D1, D2, and D3, in the developing rat
-
Bates JM, St. Germain DL, Galton VA 1999 Expression profiles of the three iodothyronine deiodinases, D1, D2, and D3, in the developing rat. Endocrinology 140:844-851.
-
(1999)
Endocrinology
, vol.140
, pp. 844-851
-
-
Bates, J.M.1
St. Germain, D.L.2
Galton, V.A.3
-
25
-
-
0034691665
-
Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas
-
Huang SA, Tu HM, Harney JW, Venihaki M, Butte AJ, Kozakewich HP, Fishman SJ, Larsen PR 2000 Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med 343:185-189.
-
(2000)
N Engl J Med
, vol.343
, pp. 185-189
-
-
Huang, S.A.1
Tu, H.M.2
Harney, J.W.3
Venihaki, M.4
Butte, A.J.5
Kozakewich, H.P.6
Fishman, S.J.7
Larsen, P.R.8
-
26
-
-
3242804522
-
The concentration of thyroid hormones and activities of iodothyronine deiodinases are altered in human brain gliomas
-
Nauman P, Bonicki W, Michalik R, Warzecha A, Czernicki Z 2004 The concentration of thyroid hormones and activities of iodothyronine deiodinases are altered in human brain gliomas. Folia Neuropathol 42:67-73.
-
(2004)
Folia Neuropathol
, vol.42
, pp. 67-73
-
-
Nauman, P.1
Bonicki, W.2
Michalik, R.3
Warzecha, A.4
Czernicki, Z.5
-
27
-
-
0033279284
-
Regulation of type 3 iodothyronine deiodinase expression in cultured rat astrocytes: Role of the Erk cascade
-
Pallud S, Ramauge M, Gavaret JM, Lennon AM, Munsch N, St. Germain DL, Pierre M, Courtin F 1999 Regulation of type 3 iodothyronine deiodinase expression in cultured rat astrocytes: role of the Erk cascade. Endocrinology 140:2917-2923.
-
(1999)
Endocrinology
, vol.140
, pp. 2917-2923
-
-
Pallud, S.1
Ramauge, M.2
Gavaret, J.M.3
Lennon, A.M.4
Munsch, N.5
St. Germain, D.L.6
Pierre, M.7
Courtin, F.8
-
28
-
-
8144231119
-
The role of MAP kinases in rapid gene induction after lesioning of the rat sciatic nerve
-
Zrouri H, Le Goascogne C, Li WW, Pierre M, Courtin F 2004 The role of MAP kinases in rapid gene induction after lesioning of the rat sciatic nerve. Eur J Neurosci 20:1811-1818.
-
(2004)
Eur J Neurosci
, vol.20
, pp. 1811-1818
-
-
Zrouri, H.1
Le Goascogne, C.2
Li, W.W.3
Pierre, M.4
Courtin, F.5
-
29
-
-
46349106779
-
Oxidative stress regulates type 3 deiodinase and type 2 deiodinase in cultured rat astrocytes
-
Lamirand A, Pallud-Mothre S, Ramauge M, Pierre M, Courtin F 2008 Oxidative stress regulates type 3 deiodinase and type 2 deiodinase in cultured rat astrocytes. Endocrinology 149:3713-3721.
-
(2008)
Endocrinology
, vol.149
, pp. 3713-3721
-
-
Lamirand, A.1
Pallud-Mothre, S.2
Ramauge, M.3
Pierre, M.4
Courtin, F.5
-
30
-
-
79952180384
-
Thyrotrophin receptor signaling dependence of Brafinduced thyroid tumor initiation in mice
-
Franco AT, Malaguarnera R, Refetoff S, Liao XH, Lundsmith E, Kimura S, Pritchard C, Marais R, Davies TF, Weinstein LS, Chen M, Rosen N, Ghossein R, Knauf JA, Fagin JA 2011 Thyrotrophin receptor signaling dependence of Brafinduced thyroid tumor initiation in mice. Proc Natl Acad Sci USA 108:1615-1620.
-
(2011)
Proc Natl Acad Sci USA
, vol.108
, pp. 1615-1620
-
-
Franco, A.T.1
Malaguarnera, R.2
Refetoff, S.3
Liao, X.H.4
Lundsmith, E.5
Kimura, S.6
Pritchard, C.7
Marais, R.8
Davies, T.F.9
Weinstein, L.S.10
Chen, M.11
Rosen, N.12
Ghossein, R.13
Knauf, J.A.14
Fagin, J.A.15
-
31
-
-
77956426014
-
Expression of SMAD proteins, TGF-beta/activin signaling mediators, in human thyroid tissues
-
Matsuo SE, Fiore AP, Siguematu SM, Ebina KN, Friguglietti CU, Ferro MC, Kulcsar MA, Kimura ET 2010 Expression of SMAD proteins, TGF-beta/activin signaling mediators, in human thyroid tissues. Arq Bras Endocrinol Metabol 54: 406-412.
-
(2010)
Arq Bras Endocrinol Metabol
, vol.54
, pp. 406-412
-
-
Matsuo, S.E.1
Fiore, A.P.2
Siguematu, S.M.3
Ebina, K.N.4
Friguglietti, C.U.5
Ferro, M.C.6
Kulcsar, M.A.7
Kimura, E.T.8
-
32
-
-
68349118960
-
Role of transforming growth factor beta in the regulation of thyroid function and growth
-
Pisarev MA, Thomasz L, Juvenal GJ 2009 Role of transforming growth factor beta in the regulation of thyroid function and growth. Thyroid 19:881-892.
-
(2009)
Thyroid
, vol.19
, pp. 881-892
-
-
Pisarev, M.A.1
Thomasz, L.2
Juvenal, G.J.3
-
33
-
-
0031724669
-
Expression of transforming growth factor-beta1 and transforming growth factor-beta Type-II receptor mRNA in papillary thyroid carcinoma
-
Matoba H, Sugano S, Yamaguchi N, Miyachi Y 1998 Expression of transforming growth factor-beta1 and transforming growth factor-beta Type-II receptor mRNA in papillary thyroid carcinoma. Horm Metab Res 30:624-628.
-
(1998)
Horm Metab Res
, vol.30
, pp. 624-628
-
-
Matoba, H.1
Sugano, S.2
Yamaguchi, N.3
Miyachi, Y.4
-
34
-
-
79960381628
-
Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFbeta signaling
-
Knauf JA, Sartor MA, Medvedovic M, Lundsmith E, Ryder M, Salzano M, Nikiforov YE, Giordano TJ, Ghossein RA, Fagin JA 2011 Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFbeta signaling. Oncogene 30:3153-3162.
-
(2011)
Oncogene
, vol.30
, pp. 3153-3162
-
-
Knauf, J.A.1
Sartor, M.A.2
Medvedovic, M.3
Lundsmith, E.4
Ryder, M.5
Salzano, M.6
Nikiforov, Y.E.7
Giordano, T.J.8
Ghossein, R.A.9
Fagin, J.A.10
-
35
-
-
4344598164
-
The thyroid hormone receptor is a suppressor of ras-mediated transcription, proliferation, and transformation
-
Garcia-Silva S, Aranda A 2004 The thyroid hormone receptor is a suppressor of ras-mediated transcription, proliferation, and transformation. Mol Cell Biol 24:7514-7523.
-
(2004)
Mol Cell Biol
, vol.24
, pp. 7514-7523
-
-
Garcia-Silva, S.1
Aranda, A.2
-
36
-
-
84859893531
-
Activation of tumor cell proliferation by thyroid hormone in a mouse model of follicular thyroid carcinoma
-
Lu C, Zhu X, Willingham MC, Cheng SY 2012 Activation of tumor cell proliferation by thyroid hormone in a mouse model of follicular thyroid carcinoma. Oncogene 31:2007-2016.
-
(2012)
Oncogene
, vol.31
, pp. 2007-2016
-
-
Lu, C.1
Zhu, X.2
Willingham, M.C.3
Cheng, S.Y.4
-
37
-
-
84859315369
-
Is there a role for inherited TR betamutation in human carcinogenesis?
-
Weinert LS, Ceolin L, Romitti M, Camargo EG, Maia AL 2012 Is there a role for inherited TR betamutation in human carcinogenesis? Arq Bras Endocrinol Metabol 56:67-71.
-
(2012)
Arq Bras Endocrinol Metabol
, vol.56
, pp. 67-71
-
-
Weinert, L.S.1
Ceolin, L.2
Romitti, M.3
Camargo, E.G.4
Maia, A.L.5
-
38
-
-
39449088036
-
Hypoxia-inducible factor induces local thyroid hormone inactivation during hypoxic-ischemic disease in rats
-
Simonides WS, Mulcahey MA, Redout EM, Muller A, Zuidwijk MJ, Visser TJ, Wassen FW, Crescenzi A, da-Silva WS, Harney J, Engel FB, Obregon MJ, Larsen PR, Bianco AC, Huang SA 2008 Hypoxia-inducible factor induces local thyroid hormone inactivation during hypoxic-ischemic disease in rats. J Clin Invest 118:975-983.
-
(2008)
J Clin Invest
, vol.118
, pp. 975-983
-
-
Simonides, W.S.1
Mulcahey, M.A.2
Redout, E.M.3
Muller, A.4
Zuidwijk, M.J.5
Visser, T.J.6
Wassen, F.W.7
Crescenzi, A.8
Da-Silva, W.S.9
Harney, J.10
Engel, F.B.11
Obregon, M.J.12
Larsen, P.R.13
Bianco, A.C.14
Huang, S.A.15
-
39
-
-
77449147772
-
Expression of hypoxia-inducible factor 1 alpha in thyroid carcinomas
-
Burrows N, Resch J, Cowen RL, von Wasielewski R, Hoang-Vu C, West CM, Williams KJ, Brabant G 2010 Expression of hypoxia-inducible factor 1 alpha in thyroid carcinomas. Endocr Relat Cancer 17:61-72.
-
(2010)
Endocr Relat Cancer
, vol.17
, pp. 61-72
-
-
Burrows, N.1
Resch, J.2
Cowen, R.L.3
Von Wasielewski, R.4
Hoang-Vu, C.5
West, C.M.6
Williams, K.J.7
Brabant, G.8
-
41
-
-
66149088423
-
Association between hypothyroidism and hepatocellular carcinoma: A case-control study in the United States
-
Hassan MM, Kaseb A, Li D, Patt YZ, Vauthey JN, Thomas MB, Curley SA, Spitz MR, Sherman SI, Abdalla EK, Davila M, Lozano RD, Hassan DM, Chan W, Brown TD, Abbruzzese JL 2009 Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States. Hepatology 49:1563-1570.
-
(2009)
Hepatology
, vol.49
, pp. 1563-1570
-
-
Hassan, M.M.1
Kaseb, A.2
Li, D.3
Patt, Y.Z.4
Vauthey, J.N.5
Thomas, M.B.6
Curley, S.A.7
Spitz, M.R.8
Sherman, S.I.9
Abdalla, E.K.10
Davila, M.11
Lozano, R.D.12
Hassan, D.M.13
Chan, W.14
Brown, T.D.15
Abbruzzese, J.L.16
-
42
-
-
80052245751
-
DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival
-
Luk JM, Burchard J, ZhangC, LiuAM,Wong KF, Shek FH, Lee NP, Fan ST, Poon RT, Ivanovska I, Philippar U, Cleary MA, Buser CA, Shaw PM, Lee CN, Tenen DG, Dai H, MaoM 2011 DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival. J Biol Chem 286:30706-30713.
-
(2011)
J Biol Chem
, vol.286
, pp. 30706-30713
-
-
Luk, J.M.1
Burchard, J.2
Zhang, C.3
Liu, A.M.4
Wong, K.F.5
Shek, F.H.6
Lee, N.P.7
Fan, S.T.8
Poon, R.T.9
Ivanovska, I.10
Philippar, U.11
Cleary, M.A.12
Buser, C.A.13
Shaw, P.M.14
Lee, C.N.15
Tenen, D.G.16
Dai, H.17
Mao, M.18
-
43
-
-
20444495684
-
Decreased type 1 iodothyronine deiodinase expression might be an early and discrete event in thyroid cell dedifferentiation towards papillary carcinoma
-
Souza Meyer E, Dora J, Wagner M, Maia A 2005 Decreased type 1 iodothyronine deiodinase expression might be an early and discrete event in thyroid cell dedifferentiation towards papillary carcinoma. Clin Endocrinol 62:672-678.
-
(2005)
Clin Endocrinol
, vol.62
, pp. 672-678
-
-
Souza Meyer, E.1
Dora, J.2
Wagner, M.3
Maia, A.4
|